Search International and National Patent Collections

1. (WO2018065132) USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS.

Pub. No.:    WO/2018/065132    International Application No.:    PCT/EP2017/067438
Publication Date: Fri Apr 13 01:59:59 CEST 2018 International Filing Date: Wed Jul 12 01:59:59 CEST 2017
IPC: A61K 35/744
A61K 35/745
A61K 35/747
A61K 31/00
A61K 36/258
A61P 3/10
A61P 9/00
Applicants: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Inventors: SOKOL, Harry
NATIVIDAD, Jane, Mea
LAMAS, Bruno
DUBOC, Henri
LAVIE-RICHARD, Mathias
MICHEL, Marie-Laure
LANGELLA, Philippe
Title: USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS.
Abstract:
The present invention relates to the preventive or curative treatment of metabolic syndrome and the associated disorders with AhR agonist or microorganism producing AhR agonist.